GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea · Delayed Price · Currency is KRW 6,400.00
+100.00 (1.59%)
At close: Jun 10, 2026
GFC Life Science Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 734.23 | 555.43 | -5,947 | 1,617 | -2,863 | 448.7 |
Depreciation & Amortization | 1,786 | 1,716 | 1,583 | 903.41 | 762.56 | 794.15 |
Loss (Gain) From Sale of Assets | -178.34 | -5.31 | 44.53 | -172.58 | - | -835.46 |
Asset Writedown & Restructuring Costs | - | - | - | 42.72 | 96.86 | - |
Loss (Gain) From Sale of Investments | 170.96 | 99.22 | 6,055 | -54.29 | -43.9 | -69.65 |
Loss (Gain) on Equity Investments | - | - | - | - | 323.54 | -217.23 |
Stock-Based Compensation | 140.12 | 106.3 | 96 | 71.19 | 68.22 | - |
Provision & Write-off of Bad Debts | -2.13 | -4.57 | -40.03 | 33.95 | -17.43 | 0.25 |
Other Operating Activities | -368.63 | -338.49 | 1,327 | -118.28 | 2,689 | 25.34 |
Change in Accounts Receivable | -1,134 | -819.99 | -277.54 | 83.48 | -31.51 | -53.89 |
Change in Inventory | -314.42 | -31.23 | -24.45 | 29.81 | -251.58 | 409.69 |
Change in Accounts Payable | -57.22 | 1.43 | -139.06 | -127.5 | -9.87 | 125.81 |
Change in Unearned Revenue | - | - | - | - | -7.41 | 0.38 |
Change in Income Taxes | - | - | - | - | -15.94 | -99.12 |
Change in Other Net Operating Assets | 302.68 | 88.4 | 289.21 | -1,368 | -40.91 | -939.38 |
Operating Cash Flow | 1,079 | 1,367 | 2,967 | 941.21 | 659.42 | -410.42 |
Operating Cash Flow Growth | -54.15% | -53.93% | 215.23% | 42.73% | - | - |
Capital Expenditures | -9,302 | -7,712 | -3,003 | -584.07 | -2,593 | -3,597 |
Sale of Property, Plant & Equipment | - | 15 | 10.91 | 3,184 | - | 1,199 |
Cash Acquisitions | - | - | - | 31.1 | - | 1,954 |
Sale (Purchase) of Intangibles | 379.62 | - | 310.24 | -67.17 | -13.73 | -15.85 |
Investment in Securities | -591.65 | 101.46 | -89.14 | 627.17 | -648.42 | -247.34 |
Other Investing Activities | -17.51 | -35.49 | 108.32 | -214.01 | 50.68 | -0 |
Investing Cash Flow | -9,522 | -7,621 | -2,664 | 2,977 | -3,139 | -1,157 |
Short-Term Debt Issued | - | - | 500 | 1,516 | 2,166 | 500 |
Long-Term Debt Issued | - | 3,600 | 650 | 770 | 1,100 | 2,200 |
Total Debt Issued | 3,700 | 3,600 | 1,150 | 2,286 | 3,266 | 2,700 |
Short-Term Debt Repaid | - | -1,000 | -950 | -2,012 | -1,086 | - |
Long-Term Debt Repaid | - | -2,421 | -623.94 | -3,148 | -336.12 | -1,396 |
Total Debt Repaid | -3,426 | -3,421 | -1,574 | -5,160 | -1,422 | -1,396 |
Net Debt Issued (Repaid) | 274.01 | 178.98 | -423.94 | -2,874 | 1,844 | 1,304 |
Issuance of Common Stock | 12,281 | 11,995 | 139.51 | - | - | - |
Repurchase of Common Stock | - | - | - | - | -200 | - |
Other Financing Activities | 10 | 10 | - | - | - | - |
Financing Cash Flow | 12,565 | 12,183 | -284.43 | -2,874 | 1,644 | 1,304 |
Foreign Exchange Rate Adjustments | 17.98 | 2.38 | 35.95 | - | - | - |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | 0 |
Net Cash Flow | 4,140 | 5,932 | 54.72 | 1,044 | -835.31 | -263.64 |
Free Cash Flow | -8,223 | -6,345 | -35.83 | 357.14 | -1,934 | -4,007 |
Free Cash Flow Margin | -45.02% | -35.82% | -0.21% | 2.60% | -14.51% | -33.65% |
Free Cash Flow Per Share | -1629.73 | -1317.13 | -11.28 | 344.54 | -1865.79 | -3867.17 |
Cash Interest Paid | 237.69 | 214.44 | 242.67 | - | - | - |
Cash Income Tax Paid | 19.96 | 10.85 | 2.23 | - | - | - |
Levered Free Cash Flow | - | -6,657 | - | -236.89 | -464.03 | -3,086 |
Unlevered Free Cash Flow | - | -6,470 | - | -100.59 | -335.61 | -2,949 |
Change in Working Capital | -1,203 | -761.4 | -151.83 | -1,382 | -357.22 | -556.51 |